Jeil Pharma Holdings Inc (KRX:002620)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,170.00
-80.00 (-0.97%)
At close: Jun 2, 2025, 3:30 PM KST

Jeil Pharma Holdings Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
126,186120,046180,683236,407245,618325,444
Upgrade
Market Cap Growth
-22.60%-33.56%-23.57%-3.75%-24.53%24.71%
Upgrade
Enterprise Value
350,639328,142429,021424,544404,795543,483
Upgrade
Last Close Price
8220.007820.0011694.3615235.7015769.3320811.81
Upgrade
PE Ratio
-----28.47
Upgrade
PS Ratio
0.160.150.230.300.320.43
Upgrade
PB Ratio
0.280.270.450.560.490.65
Upgrade
P/TBV Ratio
0.420.400.670.910.961.39
Upgrade
P/FCF Ratio
-593.17----
Upgrade
P/OCF Ratio
-26.43--18.33-
Upgrade
EV/Sales Ratio
0.450.420.530.540.530.71
Upgrade
EV/EBITDA Ratio
36.28112.4612.82126.4648721.6017.73
Upgrade
EV/EBIT Ratio
--20.51--24.70
Upgrade
EV/FCF Ratio
-29.861621.42----
Upgrade
Debt / Equity Ratio
0.360.360.530.390.230.30
Upgrade
Debt / EBITDA Ratio
16.6453.196.4048.4413850.204.89
Upgrade
Debt / FCF Ratio
-766.93----
Upgrade
Asset Turnover
0.880.880.920.900.860.88
Upgrade
Inventory Turnover
4.464.614.945.384.885.17
Upgrade
Quick Ratio
0.770.730.610.650.710.63
Upgrade
Current Ratio
1.121.080.930.981.131.02
Upgrade
Return on Equity (ROE)
-13.99%-15.82%-3.22%-18.07%-2.57%3.05%
Upgrade
Return on Assets (ROA)
-0.31%-0.79%1.50%-0.54%-0.63%1.59%
Upgrade
Return on Capital (ROIC)
-0.46%-1.16%2.18%-0.79%-0.89%2.19%
Upgrade
Return on Capital Employed (ROCE)
--4.50%--3.90%
Upgrade
Earnings Yield
-38.76%-42.62%-8.99%-31.54%-1.42%3.51%
Upgrade
FCF Yield
-9.31%0.17%-5.89%-13.84%-4.19%-10.29%
Upgrade
Dividend Yield
0.61%0.64%0.43%0.33%0.41%0.34%
Upgrade
Payout Ratio
-----13.88%
Upgrade
Buyback Yield / Dilution
-1.72%-----
Upgrade
Total Shareholder Return
-1.12%0.64%0.43%0.33%0.41%0.34%
Upgrade
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.